Nutritional Prognostic Factors in ALS
PEG-ALS
1 other identifier
observational
47
1 country
1
Brief Summary
Background. Several nutritional factors have been evaluated as prognostic factors for survival in ALS patients at earlier stages of the disease \[body mass index (BMI), body composition expressed as fat free mass (FFM), fat mass (FM), phase angle (PhA), low-density lipoprotein/high-density lipoprotein (LDL/HDL) ratio, cholesterol levels\], while only two studies have evaluated some of these parameters after PEG placement. Aim. BMI and cholesterol levels were evaluated as prognostic factors for survival after percutaneous endoscopic gastrostomy (PEG) placement Moreover, the relationship between body composition and BMI in a subgroup of ALS patients was evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2016
CompletedFirst Submitted
Initial submission to the registry
March 19, 2018
CompletedFirst Posted
Study publicly available on registry
April 4, 2018
CompletedApril 5, 2018
April 1, 2018
9.5 years
March 19, 2018
April 3, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
nutritional assessment
Weight and height (combined to report BMI in kg/m\^2)
at the time of PEG placement (one day)
biochemical nutritional assessment
cholesterol levels
only at the time of PEG placement (one day)
Secondary Outcomes (1)
body composition assessment
within 2 months from the PEG implantation (one day)
Interventions
BMI and cholesterol levels evaluation
Eligibility Criteria
This study included 47 consecutive patients referring to the Neurological ALS Tertiary Centre, Department of Basic Medical Sciences, Neurosciences and Sense Organs, who underwent PEG tube placement from 2006 to 2015 and were referred to the artificial nutrition team of the Gastroenterology Unit, Department of Emergency and Organ Transplantation, of the same University Hospital. All patients fulfilled revised El Escorial criteria for probable or definite classical ALS.
You may qualify if:
- ALS patients who underwent PEG tube placement from 2006 to 2015 and were referred to the artificial nutrition team of the Gastroenterology Unit
You may not qualify if:
- ALS patients without PEG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinic Hospital
Bari, 70124, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michele Barone
University of Bari
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
March 19, 2018
First Posted
April 4, 2018
Study Start
January 2, 2006
Primary Completion
June 30, 2015
Study Completion
July 31, 2016
Last Updated
April 5, 2018
Record last verified: 2018-04